(Q48635772)

13 February 2018

title

Non-NMDA receptor antagonist GYKI 52466 suppresses cortical afterdischarges in immature rats. (English)

1 reference

13 February 2018

author name string

Kubová H

1

1 reference

13 February 2018

Világi I

2

1 reference

13 February 2018

Mikulecká A

3

1 reference

13 February 2018

Mares P

4

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

13 February 2018

European Journal of Pharmacology

published in

1 reference

13 February 2018

volume

333

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

17-26

1 reference

13 February 2018

Postnatal development of locomotion in the laboratory rat

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Behavioural evidence for partial agonist properties of RO 15-1788, a benzodiazepine receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Glutamate antagonists have different effects on spontaneous locomotor activity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Participation of NMDA and non-NMDA excitatory amino acid receptors in the mediation of spinal reflex potentials in rats: an in vivo study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Excitatory amino acids and synaptic transmission: the evidence for a physiological function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Selective antagonists of benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

The ontogeny of excitatory amino acid receptors in rat forebrain--I. N-methyl-D-aspartate and quisqualate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Suppression of cortical epileptic afterdischarges by ketamine is not stable during ontogenesis in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Stable anticonvulsant action of benzodiazepines during development in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Pharmacology of cortical epileptic afterdischarges in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Antiepileptic drug mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Stability and pharmacokinetics of flumazenil in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Ketamine blocks cortical epileptic afterdischarges but not paired-pulse and frequency potentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Physiological and pathophysiological roles of excitatory amino acids during central nervous system development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

The ontogeny of excitatory amino acid receptors in the rat forebrain--II. Kainic acid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Suppression of cortical epileptic afterdischarges in developing rats by anticonvulsants increasing GABAergic inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Modification of seizure activity by electrical stimulation. II. Motor seizure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Rates of motor seizure development in rats subjected to electrical brain stimulation: strain and inter-stimulation interval effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Anticonvulsant activity of flumazenil in rats during ontogenetic development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Kindling: basic mechanisms and clinical validity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Cortical AMPA receptors: age-dependent regulation by cellular depolarization and agonist stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

A benzodiazepine recognition site associated with the non-NMDA glutamate receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

Experimental animal models of epilepsy: classification and relevance to human epileptic phenomena

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901119-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(97)01119-9

1 reference

13 February 2018

1 reference

13 February 2018